Table 2 Patient demographics and baseline characteristics
Characteristic | Flurbiprofen 8.75 mg (n = 101) | Placebo (n = 97) | Overall (n = 198) |
|---|---|---|---|
Sex, male, n (%) | 40 (39.6) | 39 (40.2) | 79 (39.9) |
P value | 0.9311 | ||
Age (years) | |||
Mean ± SD | 33.5 ± 11.0 | 34.2 ± 11.2 | 33.9 ± 11.1 |
Range | 18 – 61 | 18 – 58 | 18 – 61 |
P value | 0.6477 | ||
Duration of sore throat, n (%) | |||
1 day | 24 (23.8) | 19 (19.6) | 43 (21.7) |
2 days | 39 (38.6) | 31 (32.0) | 70 (35.4) |
3 days | 37 (36.6) | 43 (44.3) | 80 (40.4) |
4 days | 0 (0.0) | 3 (3.1) | 3 (1.5) |
5 days | 1 (1.0) | 1 (1.0) | 2 (1.0) |
P value | 0.1250 | ||
Pain severity, n (%) | |||
Moderate | 70 (69.3) | 64 (66.0) | 134 (67.7) |
Severe | 31 (30.7) | 33 (34.0) | 64 (32.3) |
P value | 0.6168 | ||
Mean TPA score ± SD | 8.0 ± 2.26 | 8.1 ± 2.58 | 8.1 ± 2.42 |
P value | 0.7630 | ||
TPA - size of tonsils, n (%) | |||
Normal or absent | 27 (26.7) | 25 (25.8) | 52 (26.3) |
Slightly enlarged | 42 (41.6) | 37 (38.1) | 79 (39.9) |
Moderately enlarged | 27 (26.7) | 31 (32.0) | 58 (29.3) |
Much enlarged | 5 (5.0) | 4 (4.1) | 9 (4.5) |
P value | 0.6635 | ||
PrAoI, n (%) | |||
No inflammation | 0 (0.0) | 1 (1.1) | 1 (0.5) |
Mild inflammation | 42 (41.6) | 37 (38.5) | 79 (40.1) |
Moderate inflammation | 52 (51.5) | 53 (55.2) | 105 (53.3) |
Severe inflammation | 7 (6.9) | 5 (5.2) | 12 (6.1) |
P value | 0.9550 | ||
Mean STPIS score ± SD | 79.1 ± 8.1 | 79.1 ± 8.4 | 79.1 ± 8.2 |
P value | 0.9972 | ||
Mean DSS score ± SD | 77.9 ± 10.6 | 78.2 ± 10.4 | 78.0 ± 10.5 |
P value | 0.8173 | ||
Mean SwoTS score ± SD | 76.0 ± 12.9 | 76.0 ± 12.8 | 76.0 ± 12.8 |
P value | 0.9739 | ||